[Results of ciprofloxacin therapy in urinary and respiratory tract infections].
Ciprofloxacin was administered to 218 patients with various urinary and respiratory tracts infections, including 142 patients with urinary tract infections and 76 patients with respiratory tract infections. Bacteriological tests and routine laboratory tests were performed thrice (before, during and after therapy) in all patients. Ciprofloxacin was administered orally in daily dose of 500 mg for 10 days. Daily dose was increased to 1000 mg in 23 patients with severe respiratory tract infections. Satisfactory results (recovery or regression of the symptoms of exacerbated chronic disease) were achieved in 185 patients (84.9%) and no effect in 10 patients (4.6%). Significant improvement or transient improvement were noted in 23 patients (10.5%).
Polubiec
A
A
Katedry i Kliniki Chorób Wewnetrznych i Hematologii II Wydziału Lekarskiego AM w Warszawie.
Jórasz
I
I
Kłos
K
K
Ozarek-Medyńska
T
T
Pietrzak
J
J
Starzyńska
R
R
Stepka
K
K
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002939:Ciprofloxacin / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D008875:Middle Aged; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D002939:Ciprofloxacin
Wyniki leczenia cyprofloksacyna zakazeń dróg moczowych i oddechowych.